New Data Supports Effectiveness of Cosentyx to Treat Psoriasis Over 4 Years
News
Novartis has released late-breaking data from an extension study of two Phase 3 clinical trials evaluating Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis. The data supported the efficacy of the treatment in the long-term, ... Read more